BFG
REGN icon

Berger Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Berger Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$232K Sell
300
-1
-0.3% -$766 0.01% 426
2025
Q4 		$232K Buy
+301
New +$204K 0.01% 421
2025
Q2 		– Sell
-377
Closed -$239K – 431
2025
Q1 		$239K Sell
377
-8
-2% -$5.5K 0.02% 376
2024
Q4 		$274K Sell
385
-6
-2% -$5.04K 0.02% 335
2024
Q3 		$411K Buy
391
+6
+2% +$6.68K 0.03% 256
2024
Q2 		$405K Buy
385
+8
+2% +$7.75K 0.03% 236
2024
Q1 		$363K Buy
377
+48
+15% +$45.6K 0.03% 251
2023
Q4 		$289K Sell
329
-3
-0.9% -$2.47K 0.03% 237
2023
Q3 		$273K Sell
332
-20
-6% -$15.7K 0.03% 222
2023
Q2 		$253K Buy
352
+18
+5% +$13.9K 0.03% 244
2023
Q1 		$274K Sell
334
-79
-19% -$59.6K 0.03% 217
2022
Q4 		$298K Buy
413
+8
+2% +$5.9K 0.04% 200
2022
Q3 		$279K Sell
405
-35
-8% -$22K 0.04% 192
2022
Q2 		$260K Sell
440
-13
-3% -$8.45K 0.04% 202
2022
Q1 		$316K Sell
453
-7,687
-94% -$4.86M 0.04% 202
2021
Q4 		$5.14M Buy
8,140
+227
+3% +$140K 0.68% 45
2021
Q3 		$4.79M Sell
7,913
-62
-0.8% -$38.5K 0.86% 35
2021
Q2 		$4.45M Buy
7,975
+399
+5% +$202K 0.81% 43
2021
Q1 		$3.58M Buy
+7,576
New +$3.69M 0.78% 52

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Berger Financial Group's REGN Position: Q1 2026 in Review

Berger Financial Group reduced its Regeneron Pharmaceuticals (REGN) stake by 0.33% in Q1 2026, selling an estimated $766 and leaving 300 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #426.

Berger Financial Group first reported a position in REGN in Q1 2021 and has held it in 19 quarters since. The position peaked at $5.14M in Q4 2021. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Berger Financial Group held 300 shares of Regeneron Pharmaceuticals worth $232K as of Q1 2026.
  • Berger Financial Group sold 1 Regeneron Pharmaceuticals share in Q1 2026, an estimated $766.
  • Regeneron Pharmaceuticals made up 0.01% of Berger Financial Group's portfolio in Q1 2026, its #426 holding.
  • Berger Financial Group first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • Berger Financial Group's Regeneron Pharmaceuticals position peaked at $5.14M in Q4 2021.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Berger Financial Group's 13F filing for Q1 2026, filed 28 Apr 2026.